Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy.
暂无分享,去创建一个
Yizhi Liu | P. Goldschmidt-Clermont | Xialin Liu | B. Annex | Yan Luo | Yong-jun Li | Ding-ding Wang
[1] Po-Len Liu,et al. High Glucose Impairs Early and Late Endothelial Progenitor Cells by Modifying Nitric Oxide–Related but Not Oxidative Stress–Mediated Mechanisms , 2007, Diabetes.
[2] J. C. Kim,et al. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy , 2007, Eye.
[3] B. Annex,et al. In Mice With Type 2 Diabetes, a Vascular Endothelial Growth Factor (VEGF)-Activating Transcription Factor Modulates VEGF Signaling and Induces Therapeutic Angiogenesis After Hindlimb Ischemia , 2007, Diabetes.
[4] P. Goldschmidt-Clermont,et al. Aging in the Atherosclerosis Milieu May Accelerate the Consumption of Bone Marrow Endothelial Progenitor Cells , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[5] N. Chaturvedi,et al. Reduced endothelial progenitor cells in European and South Asian men with atherosclerosis , 2007, European journal of clinical investigation.
[6] E. Lavik,et al. Modeling the neurovascular niche: VEGF‐ and BDNF‐mediated cross‐talk between neural stem cells and endothelial cells: An in vitro study , 2006, Journal of neuroscience research.
[7] I. Scott,et al. INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR PERSISTENT NEW VESSELS IN DIABETIC RETINOPATHY (IBEPE STUDY) , 2006, Retina.
[8] D. Link,et al. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. , 2006, Journal of the American College of Cardiology.
[9] A. Avogaro,et al. Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[10] Chi-Bin Chien,et al. Netrins Promote Developmental and Therapeutic Angiogenesis , 2006, Science.
[11] S. Ergün,et al. Neural driven angiogenesis by overexpression of nerve growth factor , 2006, Histochemistry and Cell Biology.
[12] Fan Zhang,et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes , 2006, Nature Medicine.
[13] C. Thiele,et al. Brain-Derived Neurotrophic Factor Activation of TrkB Induces Vascular Endothelial Growth Factor Expression via Hypoxia-Inducible Factor-1α in Neuroblastoma Cells , 2006 .
[14] C. Jiao,et al. Differential Healing Activities of CD34+ and CD14+ Endothelial Cell Progenitors , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[15] Roy Bicknell,et al. Neuronal clues to vascular guidance. , 2006, Experimental cell research.
[16] A. Avogaro,et al. Endothelial progenitor cells and the diabetic paradox. , 2006, Diabetes care.
[17] Jennifer L. Doyle,et al. Regulators of angiogenesis and strategies for their therapeutic manipulation. , 2006, The international journal of biochemistry & cell biology.
[18] V. Ganapathy,et al. Expression and function of glutamine transporters SN1 (SNAT3) and SN2 (SNAT5) in retinal Müller cells. , 2005, Investigative ophthalmology & visual science.
[19] D. Chen,et al. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. , 2005, Investigative ophthalmology & visual science.
[20] S. Rafii,et al. The bone marrow vascular niche: home of HSC differentiation and mobilization. , 2005, Physiology.
[21] S. Masuda,et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. , 2005, The New England journal of medicine.
[22] P. Carmeliet,et al. Common mechanisms of nerve and blood vessel wiring , 2005, Nature.
[23] A. Avogaro,et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. , 2005, Journal of the American College of Cardiology.
[24] K. Alitalo,et al. Neural guidance molecules regulate vascular remodeling and vessel navigation. , 2005, Genes & development.
[25] Marcus Fruttiger,et al. Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes , 2005, Development.
[26] R. Jain,et al. Pleiotropy of tissue-specific growth factors: from neurons to vessels via the bone marrow. , 2005, The Journal of clinical investigation.
[27] A. Zeiher,et al. Mobilizing endothelial progenitor cells. , 2005, Hypertension.
[28] S. Rafii,et al. Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. , 2005, The Journal of clinical investigation.
[29] G. Vogel. The Unexpected Brains Behind Blood Vessel Growth , 2005, Science.
[30] T. Asahara,et al. Endothelial progenitor cells for vasculogenesis. , 2005, Physiology.
[31] E. Scott,et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. , 2005, The Journal of clinical investigation.
[32] W. Stetler-Stevenson,et al. Tissue Inhibitors of Metalloproteinase 2 Inhibits Endothelial Cell Migration through Increased Expression of RECK , 2004, Cancer Research.
[33] J. P. McCoy,et al. Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[34] S. D. Fraser,et al. Semaphorin-plexin signaling guides patterning of the developing vasculature. , 2004, Developmental cell.
[35] Wei Zheng,et al. Mechanical, cellular, and molecular factors interact to modulate circulating endothelial cell progenitors. , 2004, American journal of physiology. Heart and circulatory physiology.
[36] F. Ingegnoli,et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. , 2004, Arthritis and rheumatism.
[37] D. Lackland,et al. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. , 2004, Investigative ophthalmology & visual science.
[38] B. Lévy,et al. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. , 2004, The American journal of pathology.
[39] Hyun-Jae Kang,et al. Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[40] C. Heeschen,et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells , 2003, Nature Medicine.
[41] A. Quyyumi,et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.
[42] K. Alitalo,et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.
[43] Shahin Rafii,et al. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration , 2003, Nature Medicine.
[44] G. Gurtner,et al. Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures , 2002, Circulation.
[45] M. Salis,et al. Nerve Growth Factor Promotes Angiogenesis and Arteriogenesis in Ischemic Hindlimbs , 2002, Circulation.
[46] P. Schimmel,et al. Bone marrow–derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis , 2002, Nature Medicine.
[47] D. Ribatti,et al. Nerve growth factor–endothelial cell interaction leads to angiogenesis in vitro and in vivo , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[48] David J. Anderson,et al. Sensory Nerves Determine the Pattern of Arterial Differentiation and Blood Vessel Branching in the Skin , 2002, Cell.
[49] E. Scott,et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization , 2002, Nature Medicine.
[50] M. Capogrossi,et al. Nerve growth factor induces angiogenic activity in a mouse model of hindlimb ischemia , 2002, Neuroscience Letters.
[51] J. Isner,et al. Targeting Kinin B1 Receptor for Therapeutic Neovascularization , 2002, Circulation.
[52] A. Reichenbach,et al. Hypoxia: modulation of endothelial cell proliferation by soluble factors released by retinal cells , 2001, Neuroreport.
[53] S. Fichtlscherer,et al. Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.
[54] S. Rafii,et al. Vascular Endothelial Growth Factor and Angiopoietin-1 Stimulate Postnatal Hematopoiesis by Recruitment of Vasculogenic and Hematopoietic Stem Cells , 2001, The Journal of experimental medicine.
[55] L. Calzà,et al. Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[56] J. Waltenberger. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. , 2001, Cardiovascular research.
[57] M. Kanje,et al. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk‐1 receptor , 2000, The European journal of neuroscience.
[58] A. Reichenbach,et al. VEGF release by retinal glia depends on both oxygen and glucose supply , 2000, Neuroreport.
[59] S. Rafii,et al. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. , 2000, Development.
[60] B. Christy,et al. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. , 2000, The Journal of clinical investigation.
[61] R. Ransohoff,et al. Surprising Pleiotropy of Nerve Growth Factor in the Treatment of Experimental Autoimmune Encephalomyelitis , 2000, The Journal of experimental medicine.
[62] G. Lundborg,et al. Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts , 1999, Brain Research.
[63] G. Onder,et al. Effect of topical application of nerve-growth factor on pressure ulcers , 1999, The Lancet.
[64] G. Lundborg,et al. Vascular Endothelial Growth Factor Has Neurotrophic Activity and Stimulates Axonal Outgrowth, Enhancing Cell Survival and Schwann Cell Proliferation in the Peripheral Nervous System , 1999, The Journal of Neuroscience.
[65] J. Isner,et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.
[66] M. D. Simone,et al. Nerve growth factor: a neurotrophin with activity on cells of the immune system , 1999, Microscopy research and technique.
[67] Hiroshi Takahashi,et al. Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon , 1999, Nature Medicine.
[68] Haruchika Masuda,et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.
[69] A. Samii,et al. Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats , 1999, Neuroscience Letters.
[70] L. Jingjing,et al. Human Müller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor. , 1999, Investigative ophthalmology & visual science.
[71] A. Lambiase,et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. , 1998, The New England journal of medicine.
[72] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[73] C. Guidry. Isolation and characterization of porcine Müller cells. Myofibroblastic dedifferentiation in culture. , 1996, Investigative ophthalmology & visual science.
[74] P. Tofilon,et al. Hypoxia‐induced vascular endothelial growth factor expression in normal rat astrocyte cultures , 1995, Glia.
[75] E. de Juan,et al. Primary culture of human retinal glia. , 1991, Investigative ophthalmology & visual science.
[76] H. Krutzsch,et al. Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells , 1990, The Journal of cell biology.
[77] M. Dunnwald,et al. Biology of bone marrow-derived endothelial cell precursors. , 2007, American journal of physiology. Heart and circulatory physiology.
[78] S. Nikol,et al. Therapeutic angiogenesis for peripheral artery disease: stem cell therapy. , 2007, VASA. Zeitschrift fur Gefasskrankheiten.
[79] G. Vogel. Developmental biology. The unexpected brains behind blood vessel growth. , 2005, Science.
[80] Frank J T Staal,et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. , 2004, Diabetes.
[81] R. Hebbel,et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. , 2000, The Journal of clinical investigation.
[82] M. Derwahl,et al. Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy. , 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.